ADJUVANT TREATMENT OF FULLY RESECTED STAGE III COLON CANCER WITH FOLFOX-4 VERSUS FOLFOX-4 PLUS CETUXIMAB

Update Il y a 4 ans
Reference: EUCTR2005-003463-23

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of the study is to assess and to compare the disease free survival curves according to treatment arm in patients with completely resected stage III colon cancer and KRAS wild-type tumor status (ITT KRAS wild-type population).


Inclusion criteria

  • FULLY RESECTED STAGE III COLON CANCER